Special Issue "20th Anniversary of Pharmaceuticals–Advances in Radiopharmaceutical Sciences and Nuclear Medicine"

Dear Colleagues,

It is our great delight and honor to celebrate the 20th Anniversary of Pharmaceuticals with a Special Issue from the section of Radiopharmaceutical Sciences, and to invite the researchers to contribute a manuscript of original research, review, or short communication. The articles from this section of "Radiopharmaceutical Sciences" will be compiled into a dedicated book.

This Special Issue entitled “Advances in radiopharmaceutical sciences and nuclear medicine” aims to cover success stories of established radiopharmaceuticals, development of novel radiopharmaceuticals, latest advances in nuclear medicine, frontier developments, and visions for the future achievements.

The development of radiopharmaceuticals considers the design, synthesis and radiolabeling of the associated agents, their biological and preclinical evaluation, and finally clinical application. Contributions may concern targeted, pre-targeted, and non-targeted radiopharmaceuticals ranging from small molecules via peptides, peptidomimetics and antibodies and derivatives to particles for their use in gamma scintigraphy, including single photon emission tomography (SPECT), positron emission tomography (PET) and endo radiotherapy. The field of diagnostic imaging and (radio)pharmaceutical therapy guided by diagnostic imaging is of strong interest. Manuscripts on the related topics of physics, dosimetry, radiopharmacy, and hybrid imaging will also be accepted. Another area of interest is the implementation of computational chemistry for radiopharmaceutical development and machine learning for image analysis. Please refer to the keyword list below for additional details.

Dr. Irina Velikyan
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• radiopharmaceuticals, agents and probes
• radionuclides
• imaging biomarkers
• biological/preclinical evaluation
• first in-human clinical studies
• SPECT, PET/CT and PET/MRI
• labeling chemistry
• medicinal radiochemistry, (pre)clinical radiopharmacology, and radiopharmacy including GMP-compliant production
• radiopharmaceutical drug development
• radio theranostics
• hybrid imaging
• organic molecules, high-molecular weight biomolecules and nano- and microparticles
• artificial intelligence and machine learning in image analysis
• computational chemistry in radiopharmaceutical development